共 121 条
[1]
Ditzinger F(2019)Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review J Pharm Pharmacol 71 464-482
[2]
Price DJ(2015)Insoluble drug delivery strategies: review of recent advances and business prospects Acta Pharm Sin B 5 442-453
[3]
Ilie A-R(2010)New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs J Pharm Pharmacol 62 1622-1636
[4]
Köhl NJ(2008)Enhancing intestinal drug solubilisation using lipid-based delivery systems Adv Drug Deliv Rev 60 673-691
[5]
Jankovic S(2012)Lipid-based formulations for oral delivery of lipophilic drugs Drug Discov Today Technol 9 97-104
[6]
Tsakiridou G(1999)Key issues when formulating hydrophobic drugs with lipids Bull Tech Gattefosse 92 41-50
[7]
Aleandri S(2000)Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems Eur J Pharm Biopharm 11 93-98
[8]
Kalantzi L(2019)Bridging the gaps between academic research and industrial product developments of lipid-based formulations Adv Drug Deliv Rev 142 118-127
[9]
Holm R(2019)Solubility of pharmaceutical ingredients in triglycerides Eur J Pharm Biopharm 145 113-120
[10]
Nair A(2016)Rapid determination of drug solubilization versus supersaturation in natural and digested lipids Int J Pharm 513 164-174